| Description | CFM-5 has anticonvulsant activity and is used in epilepsy research. |
| Synonyms | CFM 5, CFM5 |
| molecular weight | 464.38 |
| Molecular formula | C23H18BrN3OS |
| CAS | 639507-03-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. RISHI ARUN K,et al.Therapeutic compounds and methods:WO2013033392A1. 2. Rizzo M, De Sarro G, Zappalà M, Chimirri A. Determination of new 2,3-benzodiazepines in rat plasma using high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 1999 Aug 20;731(2):207-15. PubMed PMID: 10510773. 3. De Sarro G, Rizzo M, Spagnolo C, Gitto R, De Sarro A, Scotto G, Zappala M, Chimirri A. Anticonvulsant activity and plasma level of 2,3-benzodiazepin-4-ones (CFMs) in genetically epilepsy-prone rats. Pharmacol Biochem Behav. 1999 Aug;63(4):621-7. PubMed PMID: 10462191. 4. Samovar AG, Orlovskaia EE. [Effect of biologically active agents on the feeding response of Dileptus anser]. Tsitologiia. 1979 Mar;21(3):340-6. Russian. PubMed PMID: 219570. |